We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.59B
AUM Growth
-$234M
Cap. Flow
-$159M
Cap. Flow %
-6.14%
Top 10 Hldgs %
45.98%
Holding
325
New
10
Increased
161
Reduced
104
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
301
X4 Pharmaceuticals
XFOR
$378M
$16.4K ﹤0.01%
500
RGLS
302
DELISTED
Regulus Therapeutics
RGLS
$14.4K ﹤0.01%
10,547
+184
+2% +$267
OTLK icon
303
Outlook Therapeutics
OTLK
$177M
$2.21K ﹤0.01%
500
DAL icon
304
Delta Air Lines
DAL
$60B
-4,334
Closed -$206K
EMB icon
305
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
-21,946
Closed -$1.9M
ESGE icon
306
iShares ESG Aware MSCI EM ETF
ESGE
$6.6B
-19,805
Closed -$626K
GIS icon
307
General Mills
GIS
$19.2B
-3,410
Closed -$262K
IVW icon
308
iShares S&P 500 Growth ETF
IVW
$75.6B
-3,402
Closed -$240K
JCI icon
309
Johnson Controls International
JCI
$88.7B
-3,053
Closed -$208K
MDU icon
310
MDU Resources
MDU
$4.18B
-20,335
Closed -$236K
PPG icon
311
PPG Industries
PPG
$25.2B
-1,392
Closed -$206K
SCHD icon
312
Schwab US Dividend Equity ETF
SCHD
$104B
-8,376
Closed -$203K
TCPC icon
313
BlackRock TCP Capital
TCPC
$284M
-14,276
Closed -$156K
TER icon
314
Teradyne
TER
$56.8B
-2,372
Closed -$264K
TPVG icon
315
TriplePoint Venture Growth BDC
TPVG
$188M
-11,633
Closed -$137K
WBA
316
DELISTED
Walgreens Boots Alliance
WBA
-7,073
Closed -$202K
WCC
317
WESCO International
WCC
$17.6B
-1,400
Closed -$251K
XYZ
318
Block Inc
XYZ
$48.8B
-3,233
Closed -$215K

Similar funds

Grimes & Company's Q3 2023 Portfolio in Review

As of Q3 2023, Grimes & Company held 325 positions worth $2.59B, down 8.3% from $2.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Grimes & Company withdrew a net $159M in Q3 2023, closing 15 positions and reducing 104 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in DocuSign worth $12M.

  • Grimes & Company's largest Q3 2023 buy was DocuSign: 286,831 shares worth $12M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q3 2023, an estimated $58.1M increase.
  • Grimes & Company's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $82.8M.
  • Grimes & Company fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2023, selling an estimated $1.9M.
  • Grimes & Company's ten largest holdings make up 46% of its $2.59B portfolio in Q3 2023.
  • Grimes & Company opened 10 new positions and closed 15 in Q3 2023.
  • Grimes & Company's portfolio value fell 8.3% quarter-over-quarter to $2.59B.

Based on Grimes & Company's 13F filing for Q3 2023, filed 19 Oct 2023.